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The two isomers of a cyclometallated palladium
sensitizer show different photodynamic properties
in cancer cells†
Xue-Quan Zhou, a Anja Busemann, a Michael S. Meijer, a
Maxime A. Siegler b and Sylvestre Bonnet *a
This report demonstrates that changing the position of the carbon–
metal bond in a polypyridyl cyclopalladated complex, i.e. going
from PdL1 (N^N^C^N) to PdL2 (N^N^N^C), dramatically influences
the photodynamic properties of the complex in cancer cells. This
effect is primarily attributed to the significantly difference in absorbance
and singlet oxygen quantum yields between the two isomers.
The success of cisplatin, a milestone drug in the treatment of
cancers, stimulated the generation of many platinum-based
anticancer drugs,1–3 three of which (carboplatin, oxaliplatin and
nedaplatin) are approved worldwide. However, the unselective
covalent binding of cisplatin with DNA in cancer cells and healthy
cells results in serious side effects and drug resistances, which has
encouraged the development of anticancer drugs based on alter-
native metals.4–9 In this regard, palladium(II) complexes have been
proposed as potential metal-based anticancer drugs for their similar
d8 coordination sphere and square-planar structure, compared to
platinum(II) complexes.10,11 One of them, called padeliporfin or
WST11, was recently approved for photodynamic therapy (PDT)
of prostate cancer.12 PDT is a form of light-activated anticancer
treatment. It emerges as a more patient-friendly approach due
to the controlled toxicity effect and low invasiveness of light
irradiation.13–17 In PDT, a photosensitizing agent (PS) is irradiated
by visible light at the tumor site, where it generates cytotoxic reactive
oxygen species (ROS), which induces cancer cell death.18 Polypyridyl
metal complexes typically form excellent PDT sensitizers, provided
they strongly absorb visible light.19,20 The light absorption
properties of such complexes can be tuned by changing the
metal or the ligands. Critically, good photosensitizers should be
photostable, which can be achieved using multidentate ligands.
The single coordination bonds in multidentate complexes are
no stronger than those of monodentate ligands, they are simply
less likely to all decoordinate at once.
Recently, bioactive pincer palladium complexes with tridentate
N-heterocyclic carbene ligands have been shown to possess
stable metal–carbon bonds and tuneable physicochemical
properties.10,21–24 However, intracellular substitution of the
remainingmonodentate ligandsmakes their speciation in biological
media and mode-of-action complicated to understand. In addition,
due to the smaller ionic radius of Pd2+ ions, Pd–ligand bonds are
longer and more labile than their Pt–ligand analogues,25 so that
anticancer drugs based on palladium(II) are still comparatively rare.6
To overcome these drawbacks, we investigated the design and
properties of palladium(II) PDT sensitizers built from single
tetradentate cyclometallating ligands, which are expected to
be more stable in biological media compared with the tridentate
N-heterocyclic carbene ligands. Cyclometallation was considered
for different reasons. Firstly, the strong Pd–C bond can stabilize
these compounds in biological media. Secondly, the lower charge
introduced by the cyclometallated ligand can improve the lipo-
philicity and cellular uptake of the metal complexes.7,26 Finally,
the presence of a Pd–C bond should in principle lead to a
bathochromic shift of the visible absorption bands of the metal
complex, which is key for PDT applications.27
In polypyridyl metal complexes, introducing a metal–carbon
bond usually generates a series of isomers that might have
different properties. Herein we investigated two novel cyclopal-
ladated isomers PdL1 (H2L
1 = N-(3-(pyridin-2-yl)phenyl)-[2,2 0-
bipyridin]-6-amine) and PdL2 (H2L
2 = N-(6-phenylpyridin-2-yl)-
[2,20-bipyridin]-6-amine) (Scheme 1a). In PdL1, the Pd–C bond
was introduced in a pyridyl group that is adjacent to the non-
bonded nitrogen bridge of the ligand, while in PdL2 it is
introduced in one of the terminal aromatic rings. The ligands
H2L
1 and H2L
2 were synthesized by Buchwald–Hartwig coupling
reactions (Scheme S1 and Fig. S1–S4, ESI†).28–30 Palladation was
achieved in more than 90% yield by reacting the corresponding
ligand with palladium(II) acetate in acetic acid (Scheme S1 and
Fig. S5–S8, ESI†). Neither 1HNMR (Fig. S5 and S7, ESI†) nor infrared
spectroscopy (Fig. S9, ESI†) showed any sign of a protonated
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secondary amine bridge, which altogether suggested that these
complexes were much more acidic than expected. According to
13C-APT NMR (Fig. S2, S4, S6 and S8, ESI†), the ligandsH2L
1 and
H2L
2 have six quaternary carbon peaks, while their palladium
complexes have seven, thus demonstrating that cyclometallation
did occur. Altogether PdL1 and PdL2 appear to be neutral complexes;
their identical HRMS data also demonstrated they are coordination
isomers.
Vapor diffusion of diethyl ether into a methanol solution of
PdL2 yielded red rectangular crystals suitable for X-ray structure
determination (Table S1, ESI,† and Scheme 1b). PdL2 crystallized in
the centrosymmetric P21/nmonoclinic space group. Three nitrogen
and one carbon atom were coordinated to the palladium(II) cation,
with bond lengths in the range 1.988(3)–2.028(4) Å for the three
Pd–N bonds, and a Pd–C bond distance of 2.017(4) Å. The
coordination sphere was slightly distorted, with a dihedral angle
N1–N2–N4–C21 of 2.331. t4, a structural parameter calculated by
(3601 (a + b))/(1411), where a and b are the two greatest valence
angles of the coordination sphere,31 was 0.093 in the structure
of PdL2, which is typical of an essentially square planar complex.
Deprotonation of the nitrogen bridge was evident from the
shorter distance between the amine nitrogen atoms and the
adjacent pyridine carbon atoms (C10–N3 = 1.353(4) Å and
C11–N3 = 1.349(4) Å), compared to that found in metal complexes
with protonated nitrogen bridges (N–C distances in the range 1.36 Å
to 1.39 Å).29,30 Also, unlike for [Fe(Hbbpya)(NCS)2],
32 no residual
electron density was found near the bridging N atom in the
structure of PdL2. Finally, the asymmetric unit contained no
counter-ions. In summary, single crystal X-ray crystallography is
consistent with NMR and IR data, showing that PdL1 and PdL2
are neutral species because deprotonation of the nitrogen bridge
becomes very easy upon coordination.
The absorption spectrum of both complexes in PBS :DMSO
(1 : 1) solution at 310 K (Fig. S10, ESI†) presented no significant
changes over 24 hours, suggesting that the complexes were
thermally stable under such conditions. Similar results were
obtained in cell-growing medium (Fig. S11, ESI†), demonstrating
good stability under such conditions. The partition coefficients
(logPow) of the palladium complexes were determined by the
shake-flask method (Table S2, ESI†). logPow was lower for PdL
1
(0.64) than for PdL2 (+0.046), confirming the higher solubility in
water of the former, compared to the latter. Their cytotoxicity was
tested in lung (A549) and skin (A431) cancer cell lines, both in the
dark and upon blue light activation. Low doses of blue light were
chosen (455 nm, 5min, 10.5 mW cm2, 3.2 J cm2) which have by
themselves no effect on cell growth.33 The cell growth inhibition
effective concentrations (EC50) of PdL
1 and PdL2 are reported in
Table 1, and the dose–response curves are shown in Fig. 1 and
Fig. S12 (ESI†). In the dark both compounds showed significant
anticancer activity, with an EC50 around 10 mM for PdL
1 and PdL2
in A549 cells, respectively. After blue light activation, PdL1
showed a notable 13- or 4.0-fold increase in cytotoxicity in A549
and A431, respectively, while PdL2 showed a negligible photo-
index of 1.3 or 1.4, respectively. The difference in photocytotoxi-
city between the two coordination isomers was quite intriguing.
To investigate the reason for such a difference, we first measured
the singlet oxygen (1O2) generation quantum yield (jD) of these
two isomers in CD3OD spectroscopically. jD was more than twice
higher for PdL1 (0.89) than for PdL2 (0.38, Fig. 2b and Table S3,
ESI†), and higher than the reference [Ru(bpy)3]Cl2 (0.73).
34
However, PdL2 was still a decent 1O2 generator. In methanol,
the absorbance spectra of both complexes (Fig. 2) were similar
in the 270–300 nm region; however, PdL1 had a much higher
absorption in the blue region with labsmax = 422 nm, compared
to PdL2 that absorbed in the near-UV region (labsmax = 347 nm).
In this solvent the molar absorptivity at 455 nm for PdL1 and
Scheme 1 (a) Synthesis of PdL1 and PdL2; (b) displacement ellipsoid plot
(50% probability level) of PdL2 at 110(2) K (bond distance: Pd–N1 2.060(3) Å,
Pd–N2 2.028(4) Å, Pd–N4 1.988(3) Å, Pd–C21 2.017(4) Å); angle: N4–Pd1–
C21 81.99(15)1, N4–Pd1–N2 92.66(16)1, C21–Pd1–N2 174.65(18)1, N4–Pd1–
N1 172.2(2)1, C21–Pd1–N1 105.02(17)1, N2–Pd1–N1 80.33(13)1.
Table 1 The cell growing inhibition effective concentrations (EC50 in mM)
of PdL1 and PdL2 towards A549 and A431 human cancer cell lines. 95%
confidence interval (CI in mM) and photoindex (PI = EC50, dark/EC50, light)
are also indicated
Complexes
EC50 (mM)
A549 CI A431 CI
PdL1 Dark 12 +3.0 20 +4.0
3.0 3.0
Light 0.9 +0.8 5.0 +2.0
0.5 1.0
PI 13 4.0
PdL2 Dark 8.0 +2.0 14 +2.0
1.0 1.0
Light 6.0 +0.8 10 +1.0
0.7 1.0
PI 1.3 1.4
Irradiation condition: 455 nm blue light, 5 min, 10.5 mW cm2,
3.2 J cm2. Data is the mean over three independent experiments.
Fig. 1 Dose–response curves for A549 cells incubated with palladium
complexes and irradiated 5 min with blue light (blue data points), or in the
dark (black data points).
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PdL2 was 2004 M1 cm1 and 133 M1 cm1, respectively,
indicating a 15-fold enhanced absorption of PdL1 in the blue
region, compared with PdL2. Considering their similar lifetime
(0.271 vs. 0.333 ns for the main component of their biexponential
decay, Table S3 and Fig. S13, ESI†), the difference in 1O2 generation
efficiency is probably a consequence of the higher phosphorescence
quantum yield for PdL1 (0.0017) vs. PdL2 (0.00084, Table S3, ESI†),
which points to the slower non-radiative decay pathways for the
former, compared to the latter. Altogether, the dramatically higher
phototoxicity of PdL1, compared to PdL2, seems to result from the
much better absorption of blue light of PdL1, coupled to its
higher phosphorescence quantum yield, which leads to higher
1O2 generation efficiency. Although different logPow values may
lead to different cell uptake and sub-cellular localization for
both isomers as well, the better photobiological properties of
PdL1 depend, at least in part, on the much better photodynamic
properties of PdL1 (e455 and jD), compared to its isomer PdL
2.
Density functional theory (DFT) calculations were performed
to understand why PdL1 exhibited higher absorption in the
blue domain than its isomer PdL2. The nature of the highest
occupied molecular orbital (HOMO) and lowest unoccupied
molecular orbitals (LUMO) is highly relevant to predict the
photophysical properties of metal complexes.34–36 As showed in
Fig. 3, the HOMO and LUMO orbitals of both isomers PdL1 and
PdL2 had p symmetry and were centered on the ligand, with a
negligible contribution of the palladium(II) center. The bridged
secondary amine is the major contributor to the HOMO of both
palladium complexes, attributing for 20.4 (PdL1) and 21.8%
(PdL2) of the electron density. The rest of the HOMO orbital
density was located in the aromatic rings directly connected to
the nitrogen bridge. By contrast, the LUMO orbitals for both
complexes were centered on the bipyridyl fragment. This suggested
that the lowest energy absorption band of both palladium
complexes should be of ligand-to-ligand charge transfer character,
from the amine to the bipyridyl.
The calculated energies of HOMOs, LUMOs and energy gaps
are listed in Table S4 (ESI†). The HOMO of PdL1 was signifi-
cantly higher in energy than that of PdL2, indicating the higher
electron-donating effect of the negatively charged carbon atom
of PdL1, compared with that of PdL2 which is further away from
the nitrogen bridge. By contrast, the LUMO energy levels of both
palladium complexes were similar, because LUMO orbitals are
located on the almost equivalent bipyridyl fragments. Such lower
energy gap of PdL1 suggested better absorption of low-energy light,
which explains the observed differences in the UV-vis spectra of
the two isomers. These results were confirmed by time-dependent
density functional theory calculations (TDDFT) for both complexes
in methanol, using COSMO to simulate solvent effects (Fig. S14,
ESI,† left). The calculated spectrum of PdL1 (Fig. S14, ESI,† left)
showed a lower energy (515 nm) for the HOMO–LUMO transition,
compared to PdL2 (449 nm). These transition energies were
increased (404 and 367 nm, respectively) by protonation of the
nitrogen bridge (Fig. S14, ESI,† right), which may happen in the
slightly acidic environment of cancer cells; however, the trend
between [Pd(HL1)]+ and [Pd(HL2)]+ was identical to that seen for
PdL1 and PdL2. Overall, calculations clearly demonstrated that a
change of the position of the carbon–metal bond had a strong
influence on the HOMO–LUMO energy gaps of these cyclo-
metallated palladium complexes.
In summary, the new cyclopalladated complex PdL1 showed
good absorbance in the blue region of the spectrum, low phos-
phorescence, and excellent singlet oxygen quantum yield (0.89),
which altogether translated into high photoindex in human
cancer cells. By contrast, its isomer PdL2 had low absorption
and low singlet oxygen quantum yield (0.38), resulting in
negligible activation by blue light in vitro. DFT calculation
showed that the higher absorption in the blue region of PdL1,
and thus its lower HOMO–LOMO energy gap, was due to the
closer proximity between the electron-rich cyclometallated aro-
matic cycle and the nitrogen bridge of the ligand, while in PdL2
both aromatic rings adjacent to the N bridge are electron-poor
pyridine rings, which lowers the HOMO energy level. To the best
of our knowledge, this study is the first report that two isomers
of organometallic prodrugs have different photobiological
properties. These results demonstrate that changing the position
of the carbon–metal bond in the coordination sphere of photo-
active organometallic prodrugs can be used to tune the energy
gap between their frontier orbitals, and hence their absorption in
the visible region of the spectrum.
Fig. 2 (a) The molar absorption coefficient (solid line) and emission
spectra (dashed line) of PdL1 (black), PdL2 (red) in CH3OH. (b) Singlet
oxygen emission spectra of [Ru(bpy)3]Cl2 (blue), PdL
1 (black), PdL2 (red) in
CD3OD irradiated with blue light (lex = 450 nm, 50 mW, 0.4 W cm
2).
Fig. 3 DFT calculation of HOMOs (bottom) and LUMOs (top) orbitals of
PdL1 and PdL2; occupied orbitals (HOMO) have red and blue lobes, and
unoccupied orbitals (LUMO) brown and cyan lobes. Element colour code:
grey = C; orange = Pd; blue = N; white = H.
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